Search Within

Jakob Dupont

  1. "Biostatistics Service"
Formats
  1. Journal Article (10)
Groups
  1. Biostatistics Service (10)
  2. Department of Medicine (10)
  3. Epidemiology and Biostatistics (10)
  4. GDMT, Medicine (10)
  5. Gynecologic Medicine Service (10)
  6. Gynecology Disease Management Team (10)

More Groups

People
  1. Carol Aghajanian (10)
  2. David Spriggs (9)
  3. Paul Sabbatini (9)
  4. Martee Hensley (8)
  5. Alexia Iasonos (6)
  6. Dennis Chi (4)

More People

Years
  1. 2008 (1)
  2. 2007 (4)
  3. 2006 (4)
  4. 2004 (1)
Publications
  1. Clinical Cancer Research (3)
  2. Gynecologic Oncology (3)
  3. International Journal of Gynecological Cancer (2)
  4. Cancer (1)
  5. Investigational New Drugs (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Elsevier Inc. (3)
  3. Lippincott Williams & Wilkins (2)
  4. Springer (1)
  5. Wiley Blackwell (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission
    Journal Article

    Diefenbach, C. S. M.; Gnjatic, S.; Sabbatini, P.; Aghajanian, C.; Hensley, M. L.; Spriggs, D. R.; Iasonos, A.; Lee, H.; Dupont, B.; Pezzulli, S.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy
    Journal Article

    Sabbatini, P.; Mooney, D.; Iasonos, A.; Thaler, H.; Aghajanian, C.; Hensley, M.; Konner, J.; Spriggs, D.; Abu-Rustum, N. R.; Dupont, J.
    International Journal of Gynecological Cancer (2007)

    Fulltext@MSK | Save
  • CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy
    Journal Article

    Juretzka, M. M.; Barakat, R. R.; Chi, D. S.; Iasonos, A.; Dupont, J.; Abu-Rustum, N. R.; Poynor, E. A.; Aghajanian, C.; Spriggs, D.; Hensley, M. L.; more...
    Gynecologic Oncology (2007)

    Fulltext@MSK | Save
  • A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors
    Journal Article

    Hensley, M. L.; Dizon, D.; Derosa, F.; Venkatraman, E.; Sabbatini, P.; Chi, D. S.; Dupont, J.; Colevas, A. D.; Spriggs, D.; Aghajanian, C.
    Investigational New Drugs (2007)

    Fulltext@MSK | Save
  • Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer
    Journal Article

    Diefenbach, C. S. M.; Shah, Z.; Iasonos, A.; Barakat, R. R.; Levine, D. A.; Aghajanian, C.; Sabbatini, P.; Hensley, M. L.; Konner, J.; Tew, W.; more...
    Gynecologic Oncology (2007)

    Fulltext@MSK | Save
  • Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Journal Article

    Sabbatini, P.; Dupont, J.; Aghajanian, C.; Derosa, F.; Poynor, E.; Anderson, S.; Hensley, M.; Livingston, P.; Iasonos, A.; Spriggs, D.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning
    Journal Article

    Hensley, M. L.; Correa, D. D.; Thaler, H.; Wilton, A.; Venkatraman, E.; Sabbatini, P.; Chi, D. S.; Dupont, J.; Spriggs, D.; Aghajanian, C.
    Gynecologic Oncology (2006)

    Fulltext@MSK | Save
  • Topotecan and liposomal doxorubicin in recurrent ovarian cancer: Is sequence important?
    Journal Article

    Dupont, J.; Aghajanian, C.; Andrea, G.; Lovegren, M.; Chuai, S.; Venkatraman, E.; Hensley, M.; Anderson, S.; Spriggs, D.; Sabbatini, P.
    International Journal of Gynecological Cancer (2006)

    Fulltext@MSK | Save
  • Lysophosphatidic acid acyltransferase-β (LPAAT-β) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival
    Journal Article

    Diefenbach, C. S. M.; Soslow, R. A.; Iasonos, A.; Linkov, I.; Hedvat, C.; Bonham, L.; Singer, J.; Barakat, R. R.; Aghajanian, C.; Dupont, J.
    Cancer (2006)

    Fulltext@MSK | Save
  • Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: Results of a phase I/II trial
    Journal Article

    Sabbatini, P.; Aghajanian, C.; Leitao, M.; Venkatraman, E.; Anderson, S.; Dupont, J.; Dizon, D.; O'Flaherty, C.; Bloss, J.; Chi, D.; more...
    Clinical Cancer Research (2004)

    Fulltext@MSK | Save